512 related articles for article (PubMed ID: 32403220)
21. IL-23 in inflammatory bowel diseases and colon cancer.
Neurath MF
Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
[TBL] [Abstract][Full Text] [Related]
22. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
23. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
24. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
[TBL] [Abstract][Full Text] [Related]
25. Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile.
Calderón-Gómez E; Bassolas-Molina H; Mora-Buch R; Dotti I; Planell N; Esteller M; Gallego M; Martí M; Garcia-Martín C; Martínez-Torró C; Ordás I; Singh S; Panés J; Benítez-Ribas D; Salas A
Gastroenterology; 2016 Sep; 151(3):489-500.e3. PubMed ID: 27267052
[TBL] [Abstract][Full Text] [Related]
26. Th9 cells in inflammatory bowel diseases.
Weigmann B; Neurath MF
Semin Immunopathol; 2017 Jan; 39(1):89-95. PubMed ID: 27837255
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
Xu XR; Liu CQ; Feng BS; Liu ZJ
World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
[TBL] [Abstract][Full Text] [Related]
28. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
29. Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.
Karlsson M; Linton L; Lampinen M; Karlén P; Glise H; Befrits R; Janczewska I; Carlson M; Winqvist O; Eberhardson M
Scand J Gastroenterol; 2014 Jan; 49(1):66-74. PubMed ID: 24188321
[TBL] [Abstract][Full Text] [Related]
30. Letter: pathogenicity of Th17 cells may differ in ulcerative colitis compared with Crohn's disease.
Raza A; Shata MT
Aliment Pharmacol Ther; 2012 Jul; 36(2):204; author reply 205. PubMed ID: 22703461
[No Abstract] [Full Text] [Related]
31. Targets for new immunomodulation strategies in inflammatory bowel disease.
Monteleone G; Caruso R; Pallone F
Autoimmun Rev; 2014 Jan; 13(1):11-4. PubMed ID: 23774108
[TBL] [Abstract][Full Text] [Related]
32. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
Dharmani P; Chadee K
Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
34. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
[TBL] [Abstract][Full Text] [Related]
35. Th17-related cytokines in inflammatory bowel diseases: friends or foes?
Monteleone I; Sarra M; Pallone F; Monteleone G
Curr Mol Med; 2012 Jun; 12(5):592-7. PubMed ID: 22515978
[TBL] [Abstract][Full Text] [Related]
36. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
[TBL] [Abstract][Full Text] [Related]
37. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
38. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
39. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
Imam T; Park S; Kaplan MH; Olson MR
Front Immunol; 2018; 9():1212. PubMed ID: 29910812
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
